Ticker Details
Ocular Therapeutix, Inc. Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology.
IPO Date:	July 25, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.21%
Avg Daily Range (30 D):	$0.20 | 2.24%
Avg Daily Range (90 D):	$0.31 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	.97M
Avg Daily Volume (30 D):	2.48M
Avg Daily Volume (90 D):	4.75M

Trade Size
Avg Trade Size (Sh.):	130
Avg Trade Size (Sh.) (30 D):	103
Avg Trade Size (Sh.) (90 D):	124

Institutional Trades
Total Institutional Trades:	1,691
Avg Institutional Trade:	$2.02M
Avg Institutional Trade (30 D):	$2.08M
Avg Institutional Trade (90 D):	$1.97M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.39M
Avg Closing Trade (30 D):	$2.99M
Avg Closing Trade (90 D):	$3.57M
Avg Closing Volume:	244.02K

News

May 19, 2026 @ 5:06 PM What This Fund’s $14 Million Ocular Therape... Source: Jonathan Ponciano

Apr 22, 2026 @ 11:00 AM Ocular Therapeutixâ„¢ to Host Investor Day on ... Source: Not Specified

Feb 13, 2026 @ 10:00 PM Ocular Therapeutixâ„¢ to Announce Topline Data... Source: Na

Jan 26, 2026 @ 9:51 AM Corticosteroids Market Report 2026 - Global Indust... Source: Researchandmarkets.Com

Jan 15, 2026 @ 3:30 PM Ocular Therapeutix Shares Surge Following Reports ... Source: Dylan Berman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.44	$-.4	$-.27
Diluted EPS	$-1.44	$-.4	$-.27
Revenue	$52.04M	$10.79M	$13.25M
Gross Profit	$45.4M	$9.46M	$11.66M
Net Income / Loss	$-290.5M	$-88.61M	$-64.65M
Operating Income / Loss	$-299.44M	$-93.34M	$-69.76M
Cost of Revenue	$6.64M	$1.33M	$1.59M
Net Cash Flow	$317.02M	$-70.36M	$392.29M
PE Ratio